Population distribution and ancestry of the cancer protective MDM2 SNP285 (rs117039649)

نویسندگان

  • Stian Knappskog
  • Liv B. Gansmo
  • Khadizha Dibirova
  • Andres Metspalu
  • Cezary Cybulski
  • Paolo Peterlongo
  • Lauri Aaltonen
  • Lars Vatten
  • Pål Romundstad
  • Kristian Hveem
  • Peter Devilee
  • Gareth D. Evans
  • Dongxin Lin
  • Guy Van Camp
  • Vangelis G. Manolopoulos
  • Ana Osorio
  • Lili Milani
  • Tayfun Ozcelik
  • Pierre Zalloua
  • Francis Mouzaya
  • Elena Bliznetz
  • Elena Balanovska
  • Elvira Pocheshkova
  • Vaidutis Kučinskas
  • Lubov Atramentova
  • Pagbajabyn Nymadawa
  • Konstantin Titov
  • Maria Lavryashina
  • Yuldash Yusupov
  • Natalia Bogdanova
  • Sergey Koshel
  • Jorge Zamora
  • David C. Wedge
  • Deborah Charlesworth
  • Thilo Dörk
  • Oleg Balanovsky
  • Per E. Lønning
چکیده

The MDM2 promoter SNP285C is located on the SNP309G allele. While SNP309G enhances Sp1 transcription factor binding and MDM2 transcription, SNP285C antagonizes Sp1 binding and reduces the risk of breast-, ovary- and endometrial cancer. Assessing SNP285 and 309 genotypes across 25 different ethnic populations (>10.000 individuals), the incidence of SNP285C was 6-8% across European populations except for Finns (1.2%) and Saami (0.3%). The incidence decreased towards the Middle-East and Eastern Russia, and SNP285C was absent among Han Chinese, Mongolians and African Americans. Interhaplotype variation analyses estimated SNP285C to have originated about 14,700 years ago (95% CI: 8,300 - 33,300). Both this estimate and the geographical distribution suggest SNP285C to have arisen after the separation between Caucasians and modern day East Asians (17,000 - 40,000 years ago). We observed a strong inverse correlation (r = -0.805; p < 0.001) between the percentage of SNP309G alleles harboring SNP285C and the MAF for SNP309G itself across different populations suggesting selection and environmental adaptation with respect to MDM2 expression in recent human evolution. In conclusion, we found SNP285C to be a pan-Caucasian variant. Ethnic variation regarding distribution of SNP285C needs to be taken into account when assessing the impact of MDM2 SNPs on cancer risk.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

MDM2 promoter SNP55 (rs2870820) affects risk of colon cancer but not breast-, lung-, or prostate cancer

Two functional SNPs (SNP285G > C; rs117039649 and SNP309T > G; rs2279744) have previously been reported to modulate Sp1 transcription factor binding to the promoter of the proto-oncogene MDM2, and to influence cancer risk. Recently, a third SNP (SNP55C > T; rs2870820) was also reported to affect Sp1 binding and MDM2 transcription. In this large population based case-control study, we genotyped ...

متن کامل

Association of the MDM2 SNP285 Polymorphism with Cancer Susceptibility: A Meta-Analysis

The mouse double minute 2 (MDM2) gene encodes a negative regulator for p53, and the polymorphism SNP285 in the promoter region of MDM2 gene has been implicated in cancer risk, but individual published studies had inconclusive results. Therefore, we performed this meta-analysis to obtain a more precise estimation between MDM2 SNP285 polymorphism and risk of cancer. A systematic literature search...

متن کامل

MDM2 SNP309 and SNP285 Act as Negative Prognostic Markers for Non-small Cell Lung Cancer Adenocarcinoma Patients

Objectives: Two functional polymorphisms in the MDM2 promoter region, SNP309T>G and SNP285G>C, have been shown to impact MDM2 expression and cancer risk. Currently available data on the prognostic value of MDM2 SNP309 in non-small cell lung cancer (NSCLC) is contradictory and unavailable for SNP285. The goal of this study was to clarify the role of these MDM2 SNPs in the outcome of NSCLC patien...

متن کامل

LETTER TO THE EDITOR MDM2 SNP309 and risk of endometrial cancer

Dear Editor, We read with interest the paper “Association between MDM2 SNP309 polymorphism and endometrial cancer risk in Polish women” by Zajac et al. in the „Polish Journal of Pathology” [1]. This paper assesses the impact of the MDM2 promoter SNP309 (rs2279744) on risk of endometrial cancer in Polish women. The data presented by the authors indicate that the SNP309G allele is associated with...

متن کامل

A 40-bp Insertion/Deletion Polymorphism of Murine Double Minute2 (MDM2) Increased the Risk of Breast Cancer in Zahedan, Southeast Iran

Background: MDM2 (Murine Double Minute2) is an oncoprotein that inhibits the P53 activity. Overexpression of MDM2 gene has been reported in several human tumors. In the present study, we aimed to evaluate the impact of 40-bp insertion/deletion (ins/del) polymorphism on the promoter of MDM2 and susceptibility to breast cancer in a sample of Iranian population. Methods: This case-control study wa...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 5  شماره 

صفحات  -

تاریخ انتشار 2014